| Date | Target |
Transaction Type Value: $mlns |
Acquirer | Seller | ||
|---|---|---|---|---|---|---|
| 2025-12-11 |
Velocity Bioworks
Life Science Durham, North Carolina Velocity Bioworks will offer integrated contract development and manufacturing services at its purpose-built, state-of-the-art facility in San Antonio. Velocity Bioworks focuses on rapidly advancing biologic programs to the clinic and will offer a broad array of analytical testing, process development, and manufacturing services. Velocity Bioworks is based in Durham, North Carolina. |
Divestiture |
Tivic
|
Scorpius Holdings
|
||
| Deal Article Deal Link | ||||||
| 2025-12-11 |
Veralox Therapeutics - VLX-1005
Life Science Frederick, Maryland Veralox Therapeutics's VLX-1005 includes all the VLX-1005 and related 12-lipoxygenase (12-LOX) assets. VLX-1005 is a novel, potent, selective small-molecule inhibitor of 12-LOX, a key pathway driving immune platelet-mediated inflammation and a contributor to the pathogenesis of HIT. Veralox Therapeutics's VLX-1005 is based in Frederick, Maryland. |
Divestiture |
Cadrenal Therapeutics
|
Veralox Therapeutics
|
||
| Deal Article Deal Link | ||||||
| 2025-12-10 |
Pharmathen - Ophthalmology Business
Life Science Amstelveen, Netherlands Pharmathen's Ophthalmology Business is primarily a glaucoma‑focused pharmaceutical portfolio. Pharmathen's Ophthalmology Business is based in Amstelveen, Netherlands. |
Divestiture |
NTC
|
Pharmathen
|
||
| Deal Article Deal Link | ||||||
| 2025-12-09 |
Staccato OBT
Life Science Mountain View, California www.staccatoobt.com Staccato OBT is a breath-activated drug-delivery platform originally developed to deliver aerosolized medicines rapidly, non-invasively, with onset times similar to intravenous administration. The technology has been applied to therapeutic programs such as loxapine for acute agitation and is being developed for other central-nervous-system indications in collaboration with biopharmaceutical partners. |
Divestiture |
Lee’s Pharmaceutical
|
Alexza Pharmaceuticals, Inc.
|
||
| Deal Article Deal Link | ||||||
| 2025-11-19 |
Factor Bioscience - Dual-CAR T Programs
Life Science Cambridge, Massachusetts Factor Bioscience's Dual-CAR T Programs are specifically designed to target patients with extramedullary disease (EMD), which we are referring to as TPST-2003 and are based in Cambridge, Massachusetts. |
Divestiture |
Tempest Therapeutics
|
Factor Bioscience
|
||
| Deal Article Deal Link | ||||||
| 2025-11-17 |
Sebela Pharmaceuticals - Bowel Prep Franchise
Life Science Roswell, Georgia Sebela Pharmaceuticals' Bowel Prep Franchise includes prescription therapies for colonoscopy preparation and is based in Roswell, Georgia. |
Divestiture |
Azurity Pharmaceuticals
|
Sebela Pharmaceuticals
|
||
| Deal Article Deal Link | ||||||
| 2025-11-13 |
CrownBio
Life Science San Diego, California www.crownbio.com CrownBio is a preclinical contract research organization (CRO) focused on oncology, immuno-oncology, inflammation, cardiovascular, and metabolic disease drug discovery. The firm provides in vitro, in vivo, and translational biology platforms, including patient-derived xenograft (PDX) models, organoids, and bioinformatics to help biopharmaceutical companies advance therapeutic programs. CrownBio was founded in 2006 and is headquartered in San Diego, California. |
Divestiture
|
Adicon
|
JSR Life Sciences Corp.
|
||
| Deal Article Deal Link | ||||||
| 2025-11-06 |
Baergic Bio
Life Science New York, New York www.baergicbio.com Baergic Bio operates as a clinical-stage pharmaceutical company focused on developing an oral small-molecule therapeutic (BAER-101) targeted at central nervous system disorders such as epilepsy and anxiety. Baergic Bio was founded in December 2019 and is headquartered in New York, New York. |
Divestiture |
Axsome
|
Avenue Therapeutics
|
||
| Deal Article Deal Link | ||||||
| 2025-10-17 |
Renal Anti-Fibrotic Therapeutic Program
Life Science Rosebery, Australia The Renal Anti-Fibrotic Therapeutic Program includes a novel new chemical entity, VB4-P5, along with its associated intellectual property, regulatory documentation, and manufacturing data. The program is currently at the pre-IND (Investigational New Drug) stage of development and targets both rare and prevalent forms of kidney disease — areas with substantial unmet medical need. |
Divestiture
|
XORTX Therapeutics
|
Vectus Biosystems
|
||
| Deal Article Deal Link | ||||||
| 2025-10-15 |
JSR Life Sciences - Chromatography Business
Life Science Sunnyvale, California JSR Life Sciences' Chromatography Business provides chromatography services. |
Divestiture |
Merck
|
JSR Life Sciences Corp.
|
||
| Deal Article Deal Link | ||||||
| 2025-10-08 |
Polynoma
Life Science San Diego, California www.polynoma.com Polynoma is a U.S. immuno-oncology-focused biopharmaceutical company using its lead asset, a novel polyvalent shed antigen vaccine, seviprotimut-L, for the prevention of recurrence of melanoma. Polynoma is based in San Diego, California. |
Divestiture |
TransCode
|
CK Life Sciences Int’l.
|
||
| Deal Article Deal Link | ||||||
| 2025-10-01 |
Elutia's BioEnvelope Business
Life Science Silver Spring, Maryland Elutia's BioEnvelope Business includes the EluPro and CanGaroo bioenvelopes. Elutia's BioEnvelope Business is based in Silver Spring, Maryland. |
Divestiture
|
Boston Scientific
|
Elutia
|
||
| Deal Article Deal Link | ||||||
| 2025-09-17 |
Orflo Technologies
Life Science Ketchum, Idaho www.orflo.com Orflo Technologies is a supplier of cell analysis instruments, including flow cytometers and cell counters, consumables, and reagents. ORFLO’s two flagship products are the Moxi Go, a benchtop flow cytometer, and the Moxi Z, a cell counter. Orflo Technologies was founded in 2003 and is based in Ketchum, Idaho. |
Divestiture |
Precision Cell Systems
|
United BioChannels
|
||
| Deal Article Deal Link | ||||||
| 2025-09-10 |
Volta Labs - Callisto Platform
Life Science Boston, Massachusetts Volta Labs' Callisto Platform helps streamline sample preparation across multiple genomics workflows, supporting both Illumina and Oxford Nanopore Technologies (ONT) sequencing platforms. Volta Labs' Callisto Platform is based in Boston, Massachusetts. |
Divestiture |
Prinses Maxima Center
|
Volta Labs
|
||
| Deal Article Deal Link | ||||||
| 2025-08-25 |
Gilgamesh - Bretisilocin
Life Science New York, New York Gilgamesh's Bretisilocin is a 5-HT2A receptor agonist and 5-HT releaser, a novel, next-generation psychedelic compound designed to address development challenges observed within this class of compounds. |
Divestiture
|
AbbVie
|
Gilgamesh
|
||
| Deal Article Deal Link | ||||||
| 2025-08-07 |
Melinta Therapeutics
Life Science Parsippany, New Jersey www.melinta.com Melinta Therapeutics is a molecule drug discovery and development company focused on the structure-based design of new classes of antibiotics. Melinta Therapeutics is based in New Haven, Connecticut. |
Divestiture
|
CorMedix
|
Cempra Pharmaceuticals, Inc.
|
||
| Deal Article Deal Link | ||||||
| Avg |
$909
18.4x EBITDA 4.7x REVENUE |
|||||
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr was built to simplify the process of tracking who’s buying, selling, and what deals are happening across the private markets.
Behind every transaction is an opportunity, and Mergr gives professionals access to thousands of M&A deals, along with the investors, buyers, and sellers behind them.
The platform is powerful but easy to use — so you can quickly surface relevant transactions and move from research to action.
Full access to Mergr's investor, acquirer, and transaction data starts here.
